These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 35084664)

  • 1. Longitudinal white matter hyperintensity changes and cognitive decline in patients with minor stroke.
    Jiang J; Yao K; Huang X; Zhang Y; Shen F; Weng S
    Aging Clin Exp Res; 2022 May; 34(5):1047-1054. PubMed ID: 35084664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities.
    Xiong Y; Wong A; Cavalieri M; Schmidt R; Chu WW; Liu X; Wong KS; Mok V
    Neurotherapeutics; 2014 Jul; 11(3):606-11. PubMed ID: 24692001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Small Vessel Disease Progression on Long-term Cognitive and Functional Changes After Stroke.
    Clancy U; Makin SDJ; McHutchison CA; Cvoro V; Chappell FM; Hernández MDCV; Sakka E; Doubal F; Wardlaw JM
    Neurology; 2022 Apr; 98(14):e1459-e1469. PubMed ID: 35131905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.
    Scharf EL; Graff-Radford J; Przybelski SA; Lesnick TG; Mielke MM; Knopman DS; Preboske GM; Schwarz CG; Senjem ML; Gunter JL; Machulda M; Kantarci K; Petersen RC; Jack CR; Vemuri P
    Stroke; 2019 Nov; 50(11):3037-3044. PubMed ID: 31510903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter hyperintensity reduction and outcomes after minor stroke.
    Wardlaw JM; Chappell FM; Valdés Hernández MDC; Makin SDJ; Staals J; Shuler K; Thrippleton MJ; Armitage PA; Muñoz-Maniega S; Heye AK; Sakka E; Dennis MS
    Neurology; 2017 Sep; 89(10):1003-1010. PubMed ID: 28794252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain structure, amyloid, and behavioral features for predicting clinical progression in subjective cognitive decline.
    Liu S; Luo X; Chong JSX; Jiaerken Y; Youn SH; Zhang M; Zhou JH;
    Hum Brain Mapp; 2024 Jul; 45(10):e26765. PubMed ID: 38958401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial Relation Between White Matter Hyperintensities and Incident Lacunes of Presumed Vascular Origin: A 14-Year Follow-Up Study.
    Yi F; Cai M; Jacob MA; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Dec; 53(12):3688-3695. PubMed ID: 36189679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
    Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategic white matter hyperintensity locations associated with post-stroke cognitive impairment: A multicenter study in 1568 stroke patients.
    Coenen M; de Kort FA; Weaver NA; Kuijf HJ; Aben HP; Bae HJ; Bordet R; Chen CP; Dewenter A; Doeven T; Dondaine T; Duering M; Fang R; van der Giessen RS; Kim J; Kim BJ; de Kort PL; Koudstaal PJ; Lee M; Lim JS; Lopes R; van Oostenbrugge RJ; Staals J; Yu KH; Biessels GJ; Biesbroek JM
    Int J Stroke; 2024 Oct; 19(8):916-924. PubMed ID: 38651756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter hyperintensities are an independent predictor of cognitive decline 3 years following first-ever stroke-results from the PROSCIS-B study.
    Ali HF; Fast L; Khalil A; Siebert E; Liman T; Endres M; Villringer K; Kufner A
    J Neurol; 2023 Mar; 270(3):1637-1646. PubMed ID: 36471099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.
    Xia Y; Shen Y; Wang Y; Yang L; Wang Y; Li Y; Liang X; Zhao Q; Wu J; Chu S; Liang Z; Wang X; Qiu B; Ding H; Ding D; Cheng X; Dong Q
    Aging (Albany NY); 2020 May; 12(9):8506-8522. PubMed ID: 32388497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White Matter Imaging Correlates of Early Cognitive Impairment Detected by the Montreal Cognitive Assessment After Transient Ischemic Attack and Minor Stroke.
    Zamboni G; Griffanti L; Jenkinson M; Mazzucco S; Li L; Küker W; Pendlebury ST; Rothwell PM;
    Stroke; 2017 Jun; 48(6):1539-1547. PubMed ID: 28487328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI progression of cerebral small vessel disease and cognitive decline in patients with hypertension.
    Uiterwijk R; Staals J; Huijts M; de Leeuw PW; Kroon AA; van Oostenbrugge RJ
    J Hypertens; 2017 Jun; 35(6):1263-1270. PubMed ID: 28169884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study.
    Chappell FM; Del Carmen Valdés Hernández M; Makin SD; Shuler K; Sakka E; Dennis MS; Armitage PA; Muñoz Maniega S; Wardlaw JM
    Trials; 2017 Feb; 18(1):78. PubMed ID: 28222778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Impact of Cerebral Small Vessel Disease Changes in Patients With Hypertension.
    Jiménez-Balado J; Riba-Llena I; Abril O; Garde E; Penalba A; Ostos E; Maisterra O; Montaner J; Noviembre M; Mundet X; Ventura O; Pizarro J; Delgado P
    Hypertension; 2019 Feb; 73(2):342-349. PubMed ID: 30606062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired renal function is associated with brain atrophy and poststroke cognitive decline.
    Auriel E; Kliper E; Shenhar-Tsarfaty S; Molad J; Berliner S; Shapira I; Ben-Bashat D; Shopin L; Tene O; Rosenberg GA; Bornstein NM; Ben Assayag E
    Neurology; 2016 May; 86(21):1996-2005. PubMed ID: 27164678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
    Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
    Front Immunol; 2021; 12():803504. PubMed ID: 34956241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline white matter hyperintensities affect the course of cognitive function after small vessel disease-related stroke: a prospective observational study.
    Fruhwirth V; Enzinger C; Fandler-Höfler S; Kneihsl M; Eppinger S; Ropele S; Schmidt R; Gattringer T; Pinter D
    Eur J Neurol; 2021 Feb; 28(2):401-410. PubMed ID: 33065757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Subjective Memory Complaints With White Matter Hyperintensities and Cognitive Decline Among Older Adults in Chicago, Illinois.
    Dhana A; DeCarli C; Dhana K; Desai P; Krueger K; Evans DA; Rajan KB
    JAMA Netw Open; 2022 Apr; 5(4):e227512. PubMed ID: 35426922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.